Literature DB >> 18070095

Efficacy of the ketogenic diet in the 6-Hz seizure test.

Adam L Hartman1, Megan Lyle, Michael A Rogawski, Maciej Gasior.   

Abstract

PURPOSE: Since the ketogenic diet is effective in drug-resistant epilepsies, we sought to determine whether it is active in the 6-Hz seizure test, which identifies agents with a broader spectrum of activity than conventional antiepileptic screening tests.
METHODS: Male (3-4 week old) NIH Swiss mice were fed a normal or ketogenic diet ad libitum for 2-21 days. The intensity of the corneal stimulation current required to elicit seizures in the 6-Hz test was measured. Blood glucose and beta-hydroxybutyrate were measured on the day of seizure testing.
RESULTS: CC(50) (current intensity producing seizures in 50% of mice tested) was 50.6 mA and 15 mA in mice fed for 12 days with a ketogenic or normal diet, respectively (p < 0.001). CC(50) was elevated in separate experiments after 16, but not 2, 5, and 21 days of ketogenic diet exposure. CC(50) values of growing mice fed the normal diet does not differ, indicating CC(50) does not vary with mouse weight during a rapid growth phase. beta-Hydroxybutyrate was significantly higher, and glucose was significantly lower in mice fed the ketogenic diet than those fed the normal diet. Blood glucose and beta-hydroxybutyrate levels did not correlate with CC(50). DISCUSSION: The ketogenic diet significantly elevates the seizure threshold in the 6-Hz test in a time-specific manner. Protection from seizures in this model was not related to level of ketosis. CC(50) was insensitive to body weight in mice fed the normal diet, demonstrating that the 6-Hz model can assess anticonvulsant regimens where weight is a confounding factor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070095      PMCID: PMC2390715          DOI: 10.1111/j.1528-1167.2007.01430.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  20 in total

Review 1.  Animal models of the ketogenic diet: what have we learned, what can we learn?

Authors:  C E Stafstrom
Journal:  Epilepsy Res       Date:  1999-12       Impact factor: 3.045

2.  Comparative assay of an antiepileptic drugs by psychomotor seizure test and minimal electroshock threshold test.

Authors:  W C BROWN; D O SCHIFFMAN; E A SWINYARD; L S GOODMAN
Journal:  J Pharmacol Exp Ther       Date:  1953-03       Impact factor: 4.030

3.  The search for new drugs against epilepsy.

Authors:  J E P TOMAN; G M EVERETT; R K RICHARDS
Journal:  Tex Rep Biol Med       Date:  1952

4.  Neuropharmacologic considerations in psychic seizures.

Authors:  J E P TOMAN
Journal:  Neurology       Date:  1951 Nov-Dec       Impact factor: 9.910

5.  Path analysis shows that increasing ketogenic ratio, but not beta-hydroxybutyrate, elevates seizure threshold in the Rat.

Authors:  K J Bough; R S Chen; D A Eagles
Journal:  Dev Neurosci       Date:  1999-11       Impact factor: 2.984

6.  Dietary fat, ketosis, and seizure resistance in rats on the ketogenic diet.

Authors:  S S Likhodii; K Musa; A Mendonca; C Dell; W M Burnham; S C Cunnane
Journal:  Epilepsia       Date:  2000-11       Impact factor: 5.864

7.  The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy.

Authors:  M T Todorova; P Tandon; R A Madore; C E Stafstrom; T N Seyfried
Journal:  Epilepsia       Date:  2000-08       Impact factor: 5.864

8.  Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice.

Authors:  Rafal M Kaminski; Matthew R Livingood; Michael A Rogawski
Journal:  Epilepsia       Date:  2004-07       Impact factor: 5.864

Review 9.  The neuropharmacology of the ketogenic diet.

Authors:  Adam L Hartman; Maciej Gasior; Eileen P G Vining; Michael A Rogawski
Journal:  Pediatr Neurol       Date:  2007-05       Impact factor: 3.372

10.  Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: role of glucose and ketone bodies.

Authors:  John G Mantis; Nicole A Centeno; Mariana T Todorova; Richard McGowan; Thomas N Seyfried
Journal:  Nutr Metab (Lond)       Date:  2004-10-19       Impact factor: 4.169

View more
  19 in total

1.  Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models.

Authors:  Carl E Stafstrom; Jeffrey C Ockuly; Lauren Murphree; Matthew T Valley; Avtar Roopra; Thomas P Sutula
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

2.  Seizure tests distinguish intermittent fasting from the ketogenic diet.

Authors:  Adam L Hartman; Xiangrong Zheng; Emily Bergbower; Michiko Kennedy; J Marie Hardwick
Journal:  Epilepsia       Date:  2010-04-30       Impact factor: 5.864

Review 3.  Ketogenic diets, mitochondria, and neurological diseases.

Authors:  Lindsey B Gano; Manisha Patel; Jong M Rho
Journal:  J Lipid Res       Date:  2014-05-20       Impact factor: 5.922

4.  d-Leucine: Evaluation in an epilepsy model.

Authors:  Kylie Holden; Adam L Hartman
Journal:  Epilepsy Behav       Date:  2017-11-07       Impact factor: 2.937

Review 5.  Triheptanoin--a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment?

Authors:  Karin Borges; Ursula Sonnewald
Journal:  Epilepsy Res       Date:  2011-08-19       Impact factor: 3.045

6.  Potent anti-seizure effects of D-leucine.

Authors:  Adam L Hartman; Polan Santos; Kenneth J O'Riordan; Carl E Stafstrom; J Marie Hardwick
Journal:  Neurobiol Dis       Date:  2015-06-06       Impact factor: 5.996

7.  How does the ketogenic diet work? Four potential mechanisms.

Authors:  Nika N Danial; Adam L Hartman; Carl E Stafstrom; Liu Lin Thio
Journal:  J Child Neurol       Date:  2013-05-13       Impact factor: 1.987

Review 8.  Adenosine receptors and epilepsy: current evidence and future potential.

Authors:  Susan A Masino; Masahito Kawamura; David N Ruskin
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

Review 9.  Harnessing the power of metabolism for seizure prevention: focus on dietary treatments.

Authors:  Adam L Hartman; Carl E Stafstrom
Journal:  Epilepsy Behav       Date:  2012-10-27       Impact factor: 2.937

Review 10.  Ketogenic diets: evidence for short- and long-term efficacy.

Authors:  Eric H Kossoff; Jong M Rho
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.